Celiac Disease, Breastfeeding, and the Infant Microbiome: What Parents Actually Need to Know

May is Celiac Disease Awareness Month, and since mine is a celiac household, it’s something I am genuinely passionate about writing and educating on. So here is your Food With Thought spin on Celiac Awareness: Breastfed Infant Edition.

Celiac Facebook message boards have been especially active lately, coinciding with a wave of new diagnoses across the US, and I keep seeing some version of the same understandably worried question come up over and over again, which is some variation of:

“If I have celiac disease, am I passing gluten through my breastmilk and hurting my baby?”

usually followed closely by, “Will this make my baby develop celiac disease?” and then “Should I stop breastfeeding so my baby’s gut can heal?”

(And somewhere in the thread, there is almost always someone advising that the solution involves seventeen supplements, a stool test, and a freezer full of dairy-free egg-free cassava flour blueberry muffins, which sounds helpful in theory until you are the one trying to function on three hours of sleep.)

So let’s slow this down and clear up what we actually know.

A mother with celiac disease does not need to stop breastfeeding in order to heal her own gut or to protect her baby from celiac disease. Breastfeeding continues to provide meaningful immune support, including immune signaling factors, beneficial bacteria, human milk oligosaccharides that feed those bacteria, antibodies, and nutrients that help shape the infant microbiome and immune system. Breastmilk does not lose its biological value because a mother has celiac disease, although depending on the situation we may need to pay closer attention to maternal nutrient status and overall intake so both mom and baby are adequately supported. That is a clinical conversation, not a panic decision.

Now to the question that is really driving most of this concern, which is whether gluten related fragments can show up in breastmilk if a mother consumes gluten. What we actually have evidence for is not intact gluten protein, and not “whole gluten” passing into milk, but rather gluten immunogenic peptides, which are small digestion-resistant fragments derived from gluten proteins such as gliadin. These are the specific fragments studied in celiac disease research because of their known immune reactivity in genetically susceptible individuals.

A 2024 study by Ruiz-Carnicer and colleagues published in Frontiers in Immunology found that gluten immunogenic peptides can be detected in some breastmilk samples after maternal gluten consumption, with variability between individuals and sampling times. In other words, transfer appears to occur in small amounts in some cases, but it is inconsistent and not uniform across all samples or all participants.

That finding is real, and it is important scientifically. Where things tend to go off track is in what people assume it means.

Because detection is not the same thing as harm.

At this time, there is no clinical evidence that gluten related peptides in breastmilk cause celiac disease in infants, increase the risk of developing celiac disease, or require breastfeeding cessation or maternal gluten elimination as a preventive strategy. Celiac disease is not triggered by trace antigen exposure through breastmilk alone. It is a multifactorial immune-mediated condition involving genetic susceptibility, immune regulation, intestinal barrier function, microbiome interactions, and the pattern of gluten exposure once solid foods are introduced and the gut immune system is actively engaging dietary antigens.

So when we ask whether breastmilk gluten exposure is enough to cause celiac disease in an infant, the honest answer is that current evidence does not support that conclusion.

What makes this topic even more misunderstood is that infant immune development is not built on a model of complete antigen avoidance. The immune system is constantly learning how to interpret exposures, and breastmilk is part of that early signaling environment. This is not a simple exposure equals disease equation, even though it often gets framed that way online.

Celiac disease specifically is also far more complex than “gluten touched the baby.” Genetics are foundational, immune signaling pathways matter, the microbiome and gut health matter, and environmental exposures all interact in ways we are still actively studying. This is part of why two children can grow up in the same household, with similar diets and similar exposures, and have completely different immune outcomes.

For breastfeeding mothers with celiac disease, the clinical goal is not to stop nursing. The goal is to address the celiac disease itself with a strict gluten free diet so the small intestinal lining can heal and nutrient absorption can recover. That is where the medical impact of gluten exposure actually matters, not in breastmilk transfer fears.

And if a breastfed infant is diagnosed with celiac disease later on, that still does not automatically mean breastfeeding needs to stop. In most cases, management focuses on removing gluten from the infant’s diet once solid foods are introduced and ensuring appropriate pediatric gastroenterology follow up. Breastfeeding is typically continued because it still provides immune and microbiome support during a period when the gut is being supported and regulated.

This is also where I see a lot of maternal guilt start to show up, where mothers begin to feel like their body is the problem or that continuing to breastfeed is somehow contributing to illness. That interpretation is not supported by the evidence we currently have.

The supplement conversation around celiac disease tends to become very loud very quickly as well. Some individuals absolutely do require targeted nutrient support, especially when there has been long standing malabsorption or documented deficiencies, and nutrients like iron, vitamin D, folate, vitamin B12, and zinc are commonly involved. Targeted gut lining supports may also be indicated. But healing from celiac disease is not a contest of how many supplements someone can take. In many cases, the most impactful interventions are consistent gluten removal, adequate energy and protein intake, nutrient dense food patterns, and correcting specific deficiencies when they are identified. The body does need support, but it does not automatically require an extensive protocol to heal.

The infant microbiome piece is also important to keep in perspective, because a baby’s microbial and immune development is influenced by far more than a single dietary exposure. Breastfeeding itself, antibiotic exposures, delivery mode, infections, environmental context, and maternal microbiome patterns all contribute to early immune development. Breastmilk remains a biologically active and supportive influence in that system, even in families navigating celiac disease.

Another area where confusion often shows up is gluten introduction in infancy. For years there was interest in whether timing gluten introduction during a specific developmental window, particularly while breastfeeding, might reduce the risk of celiac disease. However, current evidence does not strongly support a protective effect from timing alone. Large studies show that age of gluten introduction does not significantly change cumulative celiac disease risk, and while some research suggests that higher gluten intake during weaning and early childhood may increase risk in genetically susceptible children, there is no clearly defined threshold that determines safety or harm.

So despite how often it gets turned into a rigid rule online, there is no single gluten introduction window that guarantees protection from celiac disease.

And if you’re still with me – while we are clearing things up, one more quick point – stool testing needs to be addressed directly because this is another area where misinformation is common. Celiac disease cannot be diagnosed with a GI MAP, a microbiome stool panel, or any other gluten sensitivity stool test. Diagnosis is made through blood antibody testing, such as tissue transglutaminase antibodies, and sometimes endoscopy with biopsy when confirmation is needed or when results are unclear. Stool testing can provide useful information about gut ecology, but it is not a diagnostic tool for celiac disease. (If you’ve ever had a provider that has diagnosed celiac disease based on anti-gliadin IgA alone from a stool test, I respectfully suggest you be reassessed by a celiac-literate provider…)

Testing and diagnosis matter because delayed diagnosis can mean prolonged intestinal inflammation, nutrient deficiencies, and years of symptoms without answers.

I do not diagnose celiac disease. That belongs in the medical system. But I do support people who are trying to navigate the process, whether that is families who suspect something is off, parents deciding whether symptoms warrant further evaluation, or women rebuilding nourishment after diagnosis while also feeding a baby in the middle of the night and trying to make sense of all the conflicting advice coming at them.

And many of these families do not need more fear layered on top of what is already a complex situation.

They need clarity, appropriate testing, nourishment, and support that does not turn every crumb into a crisis.

Most of all, breastfeeding mothers with celiac disease need to know this: your body is not failing your baby because you have celiac disease, and continuing to breastfeed is not preventing healing.

If you’ve been sitting with this fear about your milk and your baby, I’d genuinely like to hear it. Do you have fears about your milk harming your baby, or have you been told something that made this feel confusing?